A prospective randomized trial to compare recombinant follicle stimulating hormone (rFSH) versus highly purified human menotropin (HP-hMG) for controlled ovarian stimulation on blastocyst aneuploidy rates

Authors :: D. Brasile
Sharon H. Anderson
M.J. Glassner
E.B. Davies
H. Norris
T. Hartlein
J.J. Orris
B. Gocial
Source :: Fertility and Sterility. 110:e201
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: biology
business.industry
Recombinant Follicle Stimulating Hormone
Obstetrics and Gynecology
Aneuploidy
Stimulation
medicine.disease
law.invention
Andrology
medicine.anatomical_structure
Reproductive Medicine
Randomized controlled trial
law
HMG-CoA reductase
biology.protein
Medicine
Blastocyst
Menotropin
business

Tools